A Case Control Study of Insulin Resistance in Young Patients of Age Group 14-25 Years with Acne Vulgaris Attending Tertiary Care Center

doi:10.5281/zenodo.7812615

International Journal of Medical and Pharmaceutical Research

2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7812615

Original Article

A Case Control Study of Insulin Resistance in Young Patients of Age Group 14-25 Years with Acne Vulgaris Attending Tertiary Care Center

Girishkumar M Chalawadi

Logeshwari J

Shankar Kunti

A. Venkatakrishna

DOI : 10.5281/zenodo.7812615

Published

April 10, 2023

Abstract

Background: The pathogenesis of acne vulgaris(AV) is multifactorial. Insulin resistance has been implicated in the pathogenesis of AV in few recent studies. Strong evidence of the association of insulin resistance with AV patients is lacking in the Indian population. This study was done to evaluate insulin resistance in young patients with AV. Objectives: To assess the prevalence of insulin resistance in patients aged 14-25 years with AV and to compare it between AV patients and controls. Methodology: The study group was recruited from patients attending the Dermatology department at a General Hospital for a period of 18 months to study the insulin resistance using the HOMA-IR index in the age group 14-25 years with and without AV. In this prospective case-control study, 50 cases of acne vulgaris with 50 healthy age and sex-matched controls were included. Patients were counselled and informed consent was taken. In each case, detailed history, local and systemic examination was done. Acne grading for each patient was done based on the Global Acne Grading System (GAGS). Samples for fasting blood sugar and fasting serum insulin levels were taken. HOMA-IR index > 2 was arbitrarily taken as insulin resistance. Results: Mean HOMA-IR Index in cases was 2.21 ±0.88 whereas in controls it was 1.50 ±0.58 (p<0.05). The prevalence of insulin resistance was significantly higher in cases (56%) compared with controls (12%) (P = <0.001). The prevalence of insulin resistance did not differ significantly among the acne severity groups. Conclusions: Insulin resistance has to be considered as a major determinant in the pathogenesis of AV. The insulin resistance may be a phase of prediabetes and may develop diabetes mellitus in the future. The patients of AV should be followed up to find out about the development of the metabolic syndrome. Further large scale studies are required in this aspect to evaluate insulin resistance in AV patients. Interventional studies are required regarding target therapies directed towards insulin resistance in the treatment of AV.

Recommended Articles

Volume-4, Issue-2

Downloads

Download PDF pdf

Download XML

Citations

676 Views

395 Downloads

Share this article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.

IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.